Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A realistic UK approval window is late 2027 to mid 2028, with NHS availability through NICE technology appraisal arriving in 2029 at the earliest
Specs Purity: Research Grade Composition: 15 amino acids, synthetic peptide Stability: Resistant to enzymatic degradation in acidic environments Molecular Weight: ~1.4 kDa Reviews There are no reviews yet.
The most clinically advanced approach is that taken by DIOSynVax (Digitally Immune Optimised Synthetic Vaccines), who have partnered with PharmaJet for a first-in-human needle-free intradermal vaccine pEVAC-PS encoding their synthetic antigen T2_17 based on coronavirus RBD sequences (Table 3) [152]
We're not just talking about getting the peptide into a solution
The new program will convene experts from the regulators offices for a team-based review, instead of using the standard review system, where a drug application is sent to numerous FDA offices
Orders ship from Ontario, Canada
US$ 26.63
US$ 21.25
US$ 21.98
US$ 25.41
US$ 22.43
US$ 29.17
US$ 20.10
US$ 29.80
US$ 25.78
US$ 20.57
US$ 27.39
